ambroxol
Showing 1 - 8 of 8
Amyotrophic Lateral Sclerosis Trial in Australia (Ambroxol, Placebo)
Recruiting
- Amyotrophic Lateral Sclerosis
- Ambroxol
- Placebo
-
Sydney, New South Wales, Australia
- +4 more
Jul 26, 2023
Gaucher Disease, Type 1 Trial in Jerusalem (Ambroxol)
Active, not recruiting
- Gaucher Disease, Type 1
- Ambroxol
-
Jerusalem, IsraelShaare Zedek Medical Center
May 24, 2022
Dementia With Lewy Bodies Trial in Haugesund (Ambroxol, Placebo)
Recruiting
- Dementia With Lewy Bodies
- Ambroxol
- Placebo
-
Haugesund, NorwayHelse Fonna
May 18, 2021
Parkinson's Disease Dementia Trial in London (Ambroxol, Placebo)
Unknown status
- Parkinson's Disease Dementia
- Ambroxol
- Placebo
-
London, Ontario, CanadaParkwood Institute
Jun 19, 2020
Parkinson Disease Trial in London (Ambroxol)
Completed
- Parkinson Disease
- Ambroxol
-
London, United KingdomLeonard Wolfson Experimental Neurology Centre Clinical Research
Apr 14, 2020
Type I Gaucher Disease Trial in Monmouth Junction (Ambroxol)
Suspended
- Type I Gaucher Disease
- Ambroxol
-
Monmouth Junction, New JerseyExSAR Corporation
Feb 12, 2013
Healthy Trial in Seoul (Ambroxol and Levodropropizine, Ambroxol, Levodropropizine)
Completed
- Healthy
- Ambroxol and Levodropropizine
- +2 more
-
Seoul, Korea, Republic ofSamsung medical center
Jul 18, 2012